Observational Study of Iris Tumors
Recruiting · NCT03809585 · Observational (researchers observe without assigning treatment) · Lead sponsor: Oregon Health and Science University
View the official record on ClinicalTrials.gov →What this trial is about
This is an observational study using OCT angiography to assist with tumor characterization in melanotic and amelanotic iris lesions. OCT angiography data from healthy eyes will be compared to eyes with various types of iris tumors.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- for tumor group:
- Eyes with diagnosis of melanotic or amelanotic iris tumors
- Inclusion Criteria for healthy control group:
- Eyes without iris defects or lesions
Exclusion criteria
- both groups):
- Inability to give informed consent
- Inability to maintain stable fixation for OCT imaging
- Inability to commit to required study visits
- Eyes with concurrent retinal diseases, glaucoma, or conditions that in the opinion of the investigators might affect iris circulation
- Mature cataracts if found to limit visual potential to worse than 20/40
Where it is running
1 location listed across 1 US state.
- Oregon Health & Science University - Portland, Oregon, United States